SPBC12C2.14c is heterologously expressed in Escherichia coli as a recombinant protein fused to an N-terminal His tag for affinity purification (e.g., nickel-chelate chromatography) . Key production parameters include:
| Parameter | Value |
|---|---|
| Host Organism | E. coli |
| Tag | N-terminal His |
| Purity | >90% (SDS-PAGE validated) |
| Form | Lyophilized powder |
| Storage Buffer | Tris/PBS-based buffer, 6% trehalose, pH 8.0 |
| Reconstitution | Deionized water (0.1–1.0 mg/mL), with 5–50% glycerol for long-term storage |
This recombinant protein is distributed by commercial providers like Creative BioMart and e-scapebio, typically at a concentration of 50 µg per vial .
While SPBC12C2.14c remains uncharacterized, its recombinant form enables hypothesis-driven studies:
Gene Function Elucidation:
Knockout or RNA interference (RNAi) studies could reveal phenotypic effects, though no such data exists yet.
Biochemical assays (e.g., kinase activity, binding assays) may uncover enzymatic or interaction partners.
Protein-Protein Interaction Screens:
KEGG: spo:SPBC12C2.14c
SPBC12C2.14c is a protein-coding gene in Schizosaccharomyces pombe (fission yeast) with Entrez Gene ID 2539897. The gene encodes a hypothetical protein with an ORF nucleotide sequence length of 336bp. The corresponding mRNA and protein accession numbers are NM_001021927.1 and NP_596019.1, respectively. It's important to note that this is a PROVISIONAL REFSEQ that has not yet been subject to final NCBI review, and it is currently annotated as incomplete on both ends .
When approaching the characterization of uncharacterized proteins, it's advisable to first compile all available sequence data and annotations from multiple databases beyond NCBI, including PomBase (the dedicated S. pombe database), UniProt, and InterPro to identify any potential functional domains or motifs.
To determine if SPBC12C2.14c is located in subtelomeric regions, researchers should analyze its chromosomal location and compare it with the known organization of S. pombe chromosomes. S. pombe has three chromosomes (Ch1: 5.6 Mb; Ch2: 4.6 Mb; Ch3: 3.5 Mb) with distinct subtelomeric structures .
Methodologically, this requires:
Mapping the gene locus precisely using the complete genome sequence
Determining if it falls within the ~100 kb subtelomeric regions, which are subdivided into:
Telomere-adjacent regions (SH regions) that share high similarity (>90% identity) with at least one other subtelomere
SH-adjacent regions (SU regions) that have unique sequences but condensed chromatin structures
If SPBC12C2.14c is located in subtelomeric regions, researchers should consider the technical challenges of sequence assembly and validation in these regions, possibly requiring specialized techniques like long-read sequencing as used by Tusso et al. for natural isolates of S. pombe .
For computationally predicting functions of uncharacterized proteins like SPBC12C2.14c, implement a multi-faceted approach:
Sequence homology analysis: Use BLAST, HHpred, and PSI-BLAST against multiple databases to identify distant homologs
Domain and motif prediction: Apply InterProScan, PFAM, and PROSITE to identify functional domains
Structural prediction: Utilize AlphaFold2 or RoseTTAFold to generate 3D structure predictions
Cellular localization prediction: Apply TargetP, PSORT, and DeepLoc for subcellular localization prediction
Protein-protein interaction prediction: Use STRING database and interactome analysis
Gene neighborhood analysis: Examine synteny and gene cluster conservation across yeast species
The most effective initial characterization strategy follows a hierarchical approach:
| Experimental Level | Techniques | Expected Outcomes | Approximate Timeline |
|---|---|---|---|
| Genetic analysis | Gene knockout, conditional expression | Viability, growth phenotypes | 2-4 weeks |
| Protein expression | Recombinant expression with tags | Protein yields, solubility | 3-6 weeks |
| Localization | GFP fusion, immunofluorescence | Subcellular localization | 2-4 weeks |
| Interaction studies | Co-IP, BioID, Y2H | Protein partners | 6-8 weeks |
| Initial functional assays | Based on prediction results | Preliminary function | 4-12 weeks |
For uncharacterized proteins, it's critical to assign clear roles within the research team. Begin with genetic manipulations to determine if the gene is essential and what phenotypes result from its deletion or overexpression. Simultaneously, express the recombinant protein with appropriate tags for detection and purification. The GFP fusion approach provides valuable localization data, which can help narrow down functional hypotheses2.
To determine cell cycle-specific expression patterns of SPBC12C2.14c, implement the following experimental design:
Synchronization methods:
Temperature-sensitive cdc mutants (e.g., cdc25-22) for G2/M synchronization
Nitrogen starvation and release for G1 synchronization
Hydroxyurea treatment for S-phase arrest
Expression analysis techniques:
Quantitative RT-PCR at 15-minute intervals after synchronization release
Northern blotting for mRNA level changes
Western blotting with tagged protein versions
Single-cell RNA-seq for population heterogeneity analysis
Live cell imaging:
Time-lapse microscopy with GFP-tagged SPBC12C2.14c
Correlation with cell cycle markers (e.g., spindle pole body proteins)
The experimental design should include appropriate controls for synchronization efficiency (e.g., monitoring septation index) and loading controls for expression analysis. When collecting data, establish a standardized timeline relative to cell division events to enable proper comparison across experiments and with published datasets of known cell cycle-regulated genes in S. pombe.
When confronting the challenge of an uncharacterized protein, a systematic phenotypic screening approach is recommended:
Primary phenotypic screens:
Growth under various stress conditions (temperature, osmotic, oxidative)
Cell morphology analysis via microscopy
Cell wall integrity assays (calcofluor white, congo red sensitivity)
DNA damage response tests (UV, MMS, hydroxyurea sensitivity)
Chromosome segregation analysis (DAPI staining, missegregation rates)
Secondary screens based on primary hits:
Detailed analysis of pathways implicated in primary screens
Genetic interaction mapping with known pathway components
Synthetic genetic array (SGA) analysis
Data integration and hypothesis generation:
Correlate phenotypes with cellular processes
Design targeted biochemical assays based on phenotypic clusters
Test specific molecular functions predicted from phenotypic profiles
This experimental design follows an unbiased approach that allows the protein's function to be revealed through its phenotypic signature. Implement role division in research teams, with dedicated members focusing on phenotypic screens, others on expression/purification, and others on data analysis and integration, as outlined in experimental design approaches for complex scientific investigations2.
The optimal expression system for SPBC12C2.14c should be selected based on several considerations:
| Expression System | Advantages | Disadvantages | Suitability for SPBC12C2.14c |
|---|---|---|---|
| E. coli | Fast growth, high yields, inexpensive | May lack proper folding for eukaryotic proteins | Good initial choice for small proteins (336bp ORF suggests small size) |
| Yeast systems (S. cerevisiae, P. pastoris) | Eukaryotic folding, PTMs | Lower yields than E. coli | Excellent alternative if E. coli fails |
| S. pombe | Native environment | More complex than E. coli | Ideal for functional studies |
| Insect/Baculovirus | Advanced eukaryotic folding | Time-consuming, expensive | Consider if protein requires complex folding |
For initial purification, include a His-tag as described for other recombinant proteins , with careful optimization of lysis conditions (buffer composition, sonication parameters) to ensure maximum soluble protein recovery.
To optimize stability of recombinant SPBC12C2.14c, implement a systematic approach using response surface methodology (RSM) and Central Composite Design (CCD):
Buffer screening:
Test multiple buffer systems (Tris, Phosphate, HEPES) at various pH ranges (6.5-9.0), as demonstrated for other recombinant proteins .
Stabilizing additives assessment:
Evaluate various excipients systematically:
Polyols: Glycerol (5-30%), sucrose (5-20%)
Detergents: Triton X-100, Tween-20 at low concentrations (0.01-0.1%)
Salts: NaCl (100-500mM), ammonium sulfate (50-200mM)
Reducing agents: DTT, β-mercaptoethanol (1-5mM)
Protein stability monitoring:
UV spectroscopy measuring OD280/OD260 ratio to detect nucleic acid contamination
Monitoring OD350 to detect aggregation
Thermal shift assays to determine melting temperature
Dynamic light scattering to assess monodispersity
Data analysis using RSM/CCD approach:
Apply statistical design of experiments to identify optimal combinations of stabilizing factors and potential interaction effects between variables .
The methodology should include regular assessment of protein activity (if known) or stability metrics at defined time points and temperatures to generate reliable stability profiles. The optimization process should yield a formulation that maintains protein integrity during storage and experimental procedures.
For structural studies of SPBC12C2.14c, implement a multi-step purification strategy:
Initial purification (Capture phase):
Intermediate purification (Enhancement phase):
Ion exchange chromatography based on theoretical pI
Size exclusion chromatography to ensure monodispersity
Removal of affinity tags using specific proteases (TEV, PreScission)
Final polishing (Refinement phase):
Second size exclusion chromatography in structural biology buffer
Concentration using appropriate molecular weight cutoff filters
Quality assessment: SDS-PAGE, Western blot, mass spectrometry, dynamic light scattering
Structural preparation:
Throughout the purification process, implement rigorous quality control steps to ensure sample homogeneity and purity >95% for structural studies. Consider isotopic labeling strategies (15N, 13C) if NMR studies are planned, which would require expression in minimal media with labeled nitrogen and carbon sources.
To comprehensively investigate protein-protein interactions involving SPBC12C2.14c, implement a multi-method approach:
Affinity purification coupled with mass spectrometry (AP-MS):
Express SPBC12C2.14c with affinity tags (FLAG, HA, or TAP tag)
Perform pull-downs under native conditions
Identify binding partners through mass spectrometry
Validate interactions using reciprocal pull-downs
Proximity-based labeling:
BioID or TurboID fusion proteins to identify proximal proteins
APEX2 fusion for rapid proximity labeling
MS identification of biotinylated proteins
Yeast two-hybrid screening:
Use SPBC12C2.14c as both bait and prey
Screen against S. pombe genomic or cDNA libraries
Perform directed tests with candidate interactors
In vitro binding assays:
Surface plasmon resonance (SPR) or biolayer interferometry
Isothermal titration calorimetry (ITC)
ELISA-based interaction assays
Visualization techniques:
Fluorescence resonance energy transfer (FRET)
Bimolecular fluorescence complementation (BiFC)
Co-localization studies using fluorescence microscopy
For each method, include appropriate controls and statistical analysis to distinguish specific from non-specific interactions. Prioritize validation of interactions identified in multiple independent approaches. When interpreting results, consider that uncharacterized proteins may participate in novel complexes or pathways not currently documented in interaction databases.
To determine subcellular localization of SPBC12C2.14c, employ a comprehensive approach combining multiple techniques:
Live-cell fluorescence microscopy:
C-terminal and N-terminal GFP fusions (construct both to avoid localization artifacts)
Time-lapse imaging throughout cell cycle
Co-localization with known organelle markers:
Nucleus: Histone-RFP
ER: Sec61-RFP
Golgi: Anp1-RFP
Mitochondria: Cox4-RFP
Vacuole: FM4-64 staining
Immunofluorescence microscopy:
Generate specific antibodies against SPBC12C2.14c
Alternatively, use antibodies against epitope tags
Fixation optimization to preserve structures
Multi-channel imaging with organelle markers
Biochemical fractionation:
Cell lysis and differential centrifugation
Separation of nuclear, cytoplasmic, membrane, and organelle fractions
Western blot analysis of fractions using antibodies
Quantitative analysis of protein distribution
Inducible mislocalization:
Addition of inducible localization signals (nuclear export/import)
Assessment of phenotypic consequences of mislocalization
Correlation with protein function
Each experimental approach should include proper controls including known proteins with established localization patterns. Document localization under various growth conditions and stress responses, as cellular localization may be dynamic and condition-dependent in response to environmental changes.
For structural characterization of SPBC12C2.14c, select appropriate techniques based on protein properties and research questions:
| Technique | Advantages | Limitations | Sample Requirements |
|---|---|---|---|
| X-ray crystallography | Atomic resolution (1-2Å) | Requires crystals | 5-10mg pure protein, stable crystals |
| Cryo-EM | Works with larger complexes | Lower resolution for small proteins | 100-500μg protein, stable in thin ice |
| NMR spectroscopy | Solution dynamics, interactions | Size limitation (~30kDa) | 15N/13C labeled protein, 1-5mM concentration |
| Small-angle X-ray scattering (SAXS) | Low-resolution envelope, flexibility | No atomic details | 50-100μg protein, monodisperse sample |
| AlphaFold2 prediction | No experimental sample needed | Accuracy varies with homology | Sequence only |
Given that SPBC12C2.14c has a short ORF (336bp) suggesting a small protein of approximately 112 amino acids, both X-ray crystallography and NMR would be suitable primary approaches. The small size makes it ideal for NMR studies, which could provide not only structural information but also dynamics and potential interaction interfaces.
For experimental structure determination, optimize protein expression and purification to obtain stable, homogeneous samples as outlined in section 3.3. Complement experimental approaches with computational predictions from AlphaFold2, and validate structural models through biochemical and biophysical techniques such as circular dichroism, limited proteolysis, and crosslinking mass spectrometry.
To analyze potential homologs of SPBC12C2.14c across fungal species, implement this comprehensive approach:
Sequence-based homology search:
PSI-BLAST against fungal genomes with increasing iterations
HMMER searches using profile hidden Markov models
Sensitive search methods like HHpred to detect remote homologs
Synteny analysis to identify positional orthologs
Phylogenetic analysis:
Multiple sequence alignment using MAFFT or T-Coffee
Alignment curation to remove poorly aligned regions
Model testing to determine appropriate evolutionary model
Maximum likelihood (RAxML, IQ-TREE) and Bayesian methods (MrBayes)
Structural homology detection:
Structure prediction of SPBC12C2.14c using AlphaFold2
Structural alignment against known proteins (DALI, TM-align)
Identification of similar folds despite low sequence identity
Evolutionary rate analysis:
Calculate dN/dS ratios to detect selective pressure
Identify conserved residues as potentially functional
Analyze coevolution patterns with predicted interacting partners
Create a comprehensive table displaying sequence identity, similarity, coverage, and predicted functional conservation across species. For accurate evolutionary interpretation, consider the chromosome location of SPBC12C2.14c, as subtelomeric regions often evolve more rapidly and display higher variation between strains compared to other chromosomal regions .
To determine if SPBC12C2.14c belongs to subtelomeric gene families like the RecQ-type helicase genes (tlh1-4) identified in S. pombe , employ these specialized approaches:
Comparative sequence analysis:
Align SPBC12C2.14c with known subtelomeric gene families
Search for shared domains or sequence motifs characteristic of subtelomeric genes
Analyze sequence variations between different strain isolates
Genome architecture analysis:
Map precise chromosomal location relative to SH (subtelomeric homologous) regions
Determine if located in SH-P (telomere-proximal) or SH-D (telomere-distal) regions
Assess sequence conservation patterns typical of subtelomeric regions
Strain variation analysis:
Chromatin structure analysis:
ChIP-seq for heterochromatin marks (H3K9me, Swi6/HP1)
Analysis of transcriptional silencing in subtelomeric regions
Assessment of recombination frequencies
If SPBC12C2.14c is located in subtelomeric regions, special sequencing approaches may be needed to accurately characterize it, as standard short-read sequencing often struggles with repetitive regions. Consider long-read sequencing technologies like Oxford Nanopore or PacBio, similar to approaches used for characterizing complete sequences of S. pombe subtelomeres .
To investigate potential subtelomeric silencing or heterochromatin regulation of SPBC12C2.14c, implement these specialized approaches:
Chromatin immunoprecipitation (ChIP) analysis:
ChIP for heterochromatin marks: H3K9me2/3, H3K27me3
ChIP for heterochromatin proteins: Swi6/HP1, Clr4
ChIP for histones with activation marks as control (H3K4me3, H3K36me3)
ChIP-qPCR with primers specific for SPBC12C2.14c and control regions
Transcriptional analysis across conditions:
RT-qPCR in wild-type and heterochromatin mutants (swi6Δ, clr4Δ)
RNA-seq analysis comparing expression in different genetic backgrounds
5' RACE to identify transcription start sites
Nuclear run-on assays to measure transcription rates
Reporter gene assays:
Integration of reporter genes (GFP, lacZ) near SPBC12C2.14c
Analysis of reporter expression in different genetic backgrounds
Position effect variegation assays
Chromosome conformation analysis:
4C or Hi-C to detect interactions with other heterochromatic regions
FISH to visualize nuclear localization relative to telomeres
Live-cell imaging to track dynamics during cell cycle
If SPBC12C2.14c is subject to subtelomeric silencing, you would expect to observe enrichment of heterochromatin marks, decreased expression compared to euchromatic genes, and derepression in heterochromatin mutants. Understanding the chromatin regulation context is essential for accurate interpretation of gene function, as heterochromatin can impact both expression levels and potential functional roles of genes in these regions .
For CRISPR-based functional analysis of SPBC12C2.14c in S. pombe, implement these specialized approaches:
CRISPR knockout strategies:
Design multiple sgRNAs targeting different regions of SPBC12C2.14c
Use Cas9 nuclease for complete gene deletion
Implement precise editing with HDR templates containing selection markers
Create scarless deletions using transient selection systems
CRISPR interference (CRISPRi):
dCas9-repressor fusions (dCas9-Mxi1) for transcriptional repression
Targetable repression without altering DNA sequence
Inducible systems for temporal control of repression
Titration of repression levels for dosage studies
CRISPR activation (CRISPRa):
dCas9-activator fusions for transcriptional upregulation
Overcome potential heterochromatin silencing
Test for gain-of-function phenotypes
Implement in combination with reporter systems
CRISPR base editing and prime editing:
Create point mutations without double-strand breaks
Test the importance of specific residues
Engineer protein variants with altered function
Generate conditional alleles
When designing CRISPR experiments for uncharacterized genes, implement a graduated approach beginning with complete knockout to determine essentiality, followed by more sophisticated techniques for detailed functional characterization. Include controls targeting well-characterized genes and non-targeting guides as experimental controls. If SPBC12C2.14c is located in heterochromatic regions, optimization of CRISPR efficiency may be required, as heterochromatin can reduce CRISPR targeting efficiency.
To comprehensively assess SPBC12C2.14c function under stress conditions, implement this systematic approach:
Gene expression analysis under diverse stresses:
RT-qPCR time course after exposure to:
Temperature stress (cold shock, heat shock)
Oxidative stress (H₂O₂, menadione)
DNA damage (UV, MMS, hydroxyurea)
Nutritional stress (nitrogen starvation, carbon limitation)
Osmotic stress (sorbitol, NaCl)
RNA-seq for genome-wide context of expression changes
Comparison with known stress-responsive genes
Phenotypic analysis of deletion/overexpression strains:
Spot assays with serial dilutions on stress media
Growth curve analysis with automated systems
Microscopic analysis of cell morphology under stress
Cell survival quantification after acute stress exposure
| Stress Type | Assay Method | Measurements | Expected Timeframe |
|---|---|---|---|
| Temperature | Growth curves at 20°C, 30°C, 37°C | Doubling time, lag phase | 24-72 hours |
| Oxidative | H₂O₂ sensitivity (0.5-5mM) | Colony formation, cell death | 2-5 days |
| Genotoxic | UV survival curves | Survival rate vs. dose | 3-7 days |
| Nutritional | Growth in minimal media | Biomass, cell size changes | 1-2 weeks |
Protein localization and dynamics under stress:
Live-cell imaging of GFP-tagged SPBC12C2.14c during stress response
Quantification of localization changes and protein levels
FRAP to measure protein mobility changes under stress
Genetic interaction analysis under stress:
Synthetic genetic array (SGA) under stress conditions
Identification of condition-specific genetic interactions
Double mutant analysis with known stress response genes
This comprehensive approach will reveal if SPBC12C2.14c has stress-specific functions, potentially uncovering roles that aren't apparent under standard laboratory conditions.
To comprehensively investigate post-translational modifications (PTMs) of SPBC12C2.14c, implement this multi-faceted approach:
Mass spectrometry-based PTM mapping:
Purify tagged SPBC12C2.14c from S. pombe under different conditions
Employ bottom-up proteomics with enrichment strategies:
Phosphorylation: TiO₂, IMAC, phospho-antibodies
Ubiquitination: K-ε-GG antibodies, TUBEs
Acetylation: Anti-acetyl-lysine antibodies
SUMOylation: SUMO-TRAPS, immunoprecipitation
Apply multiple proteases for comprehensive coverage
Perform quantitative analysis across conditions
Site-specific mutagenesis validation:
Mutate identified PTM sites to non-modifiable residues
Create phosphomimetic mutations (S/T to D/E)
Assess functional consequences through phenotypic analysis
Investigate effects on localization and interactions
PTM-specific detection methods:
Phos-tag gels for phosphorylation
Western blotting with modification-specific antibodies
In vitro modification assays with purified enzymes
Proximity ligation assays for in situ detection
Dynamics and regulation analysis:
Time-course studies after stimulation or stress
Inhibitor studies to identify responsible enzymes
Genetic studies in backgrounds lacking specific modifying enzymes
Correlation with cell cycle or developmental stages
Create a comprehensive PTM map identifying the specific residues modified, the type of modification, the cellular conditions promoting modification, and the functional consequences. For uncharacterized proteins, PTM analysis can provide critical insights into regulation, localization signals, and potential functions that might not be evident from sequence analysis alone.
The most comprehensive characterization of SPBC12C2.14c requires an integrated multi-omics approach combining:
Genomic context analysis:
Transcriptomic profiling:
RNA-seq under multiple conditions
Transcription start site mapping (CAGE-seq)
mRNA stability assessment
Ribosome profiling for translation efficiency
Proteomic characterization:
Comprehensive PTM mapping
Protein-protein interaction network analysis
Protein abundance and turnover rates
Structural characterization
Functional genomics:
Phenomic analysis of mutants under diverse conditions
Genetic interaction mapping
Synthetic lethality screens
High-content imaging phenotyping
Data integration frameworks:
Network-based integration of multi-omics data
Machine learning approaches for function prediction
Comparative analysis with characterized proteins
Pathway and process enrichment analysis
This integrated approach should be implemented as an iterative process, where findings from one methodological approach inform and refine investigations using other techniques. The comprehensive characterization should culminate in testable hypotheses about SPBC12C2.14c function that can be validated through targeted experiments.
To distinguish between direct and indirect effects when studying SPBC12C2.14c, implement these specialized approaches:
Temporal resolution strategies:
Rapid induction/repression systems (tetracycline-inducible)
Auxin-inducible degron (AID) for rapid protein depletion
Time-course analyses with fine temporal resolution
Mathematical modeling of response kinetics
Direct biochemical validation:
In vitro reconstitution with purified components
Structure-function mutagenesis studies
Catalytic activity assays with direct readouts
Single-molecule techniques to observe direct interactions
Proximity-based approaches:
BioID or TurboID fusion proteins for proximity labeling
APEX2 enzyme-based proximity labeling
Crosslinking mass spectrometry (XL-MS)
FRET/BRET for direct interaction monitoring
Genetic approaches:
Epistasis analysis with known pathway components
Suppressor screens to identify genetic relationships
Separation-of-function mutations
Specificity controls with related proteins or domains
When interpreting results, construct clear criteria for what constitutes evidence of direct effects (e.g., physical interaction, immediate temporal response, biochemical activity) versus indirect effects. Develop models that explicitly distinguish between primary and secondary effects, and test these models through targeted interventions at different points in the proposed pathway.
For robust data management and reproducibility when researching uncharacterized proteins like SPBC12C2.14c, implement these essential practices:
Comprehensive documentation and metadata:
Detailed experimental protocols with exact conditions
Complete strain information including construction methods
Primer sequences, plasmid maps, and verification data
Raw data preservation with appropriate metadata
Detailed computational analysis pipelines
Statistical and experimental design considerations:
A priori power analysis to determine sample sizes
Randomization and blinding procedures where appropriate
Appropriate statistical tests with justification
Multiple testing correction for high-throughput data
Independent biological replicates (n≥3) for all key findings
Data and resource sharing:
Deposition of data in appropriate repositories:
Sequence data: GenBank, ENA
Proteomics data: PRIDE, MassIVE
Structural data: PDB, BMRB
Strain and plasmid sharing through repositories
Code sharing through GitHub or similar platforms
Preregistration of study designs when appropriate
Validation and controls:
Multiple orthogonal techniques for key findings
Appropriate positive and negative controls
Rescue experiments to confirm specificity
Independent validation in different laboratories